CVS Health Corporation (CVS) currently holds a consensus rating of Moderate Buy among Wall Street analysts.
Wall Street Analyst Consensus on CVS Health
The prevailing sentiment from financial analysts suggests a positive outlook for CVS Health. This "Moderate Buy" consensus is derived from a recent aggregation of analyst recommendations. A significant majority of analysts recommend buying the stock, with a smaller portion suggesting holding. Importantly, no analysts are currently recommending to sell shares of CVS Health.
Here's a breakdown of the analyst recommendations:
| Recommendation | Number of Analysts |
|---|---|
| Buy | 13 |
| Hold | 5 |
| Sell | 0 |
| Total | 18 |
Average Price Target for CVS
Analysts have also provided 12-month price targets for CVS Health. The average price target is set at $65.29. This target is based on the projections from 18 Wall Street analysts who have issued their forecasts within the past three months, indicating their expectations for the stock's potential value over the coming year.
Understanding the "Moderate Buy" Rating
A "Moderate Buy" rating typically indicates that analysts generally believe the stock is likely to outperform the broader market or its sector, but perhaps with less conviction than a "Strong Buy." It suggests that the company's fundamentals are sound, and there's an expectation of appreciation in its share price. For CVS, the absence of "sell" ratings further reinforces the positive sentiment, showing that analysts generally do not anticipate a decline in the stock's value based on current information.
